NCT02836288View on ClinicalTrials.gov

Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

December 20, 2016

Primary Completion Date

May 29, 2018

Study Completion Date

May 29, 2018

Conditions
CancerDepression
Interventions
DRUG

Ketamine

Ketamine 1.0 mg/kg mixed with syrup will be given by mouth once a day for 12 weeks.

OTHER

Placebo

Placebo syrup will be given by mouth once a day for 12 weeks.

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Scott A. Irwin, MD, PhD

OTHER

NCT02836288 - Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer | Biotech Hunter | Biotech Hunter